Status:
COMPLETED
Ceftriaxone in Non-neutropenic Fever
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Histiocytosis
Pediatric Patients With Cancer
Eligibility:
All Genders
Up to 22 years
Brief Summary
This is a retrospective chart review of all patients cared for at Monroe Carell Jr. Children's Hospital at Vanderbilt including the following: * patients between 2007-2009 with malignancy, Langerhans...
Eligibility Criteria
Inclusion
- Diagnosed with malignancy, Langerhans cell histiocytosis,or hemophagocytic lymphohistiocytosis from 2007 through 2010
- Under 23 years at time of diagnosis of malignancy, Langerhans cell histiocytosis,or hemophagocytic lymphohistiocytosis
- Treated at Monroe Carell Jr. Children's Hospital at Vanderbilt for aforementioned diagnosis from 2007 through 2012
- While on immunosuppressive therapy with a central venous line in place had at least one documented episode of fever (defined as ≥ 38.0°Celsius orally for over 30 minutes or ≥ 38.3°Celsius orally x1).
Exclusion
- Does not meet all inclusion criteria as stated above
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 25 2016
Estimated Enrollment :
463 Patients enrolled
Trial Details
Trial ID
NCT01225718
Start Date
August 1 2010
End Date
June 25 2016
Last Update
April 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Monroe Carrell Jr. Children's Hospital at Vanderbilt
Nashville, Tennessee, United States, 37232